Net Daş-Evcimen

754 total citations
15 papers, 623 citations indexed

About

Net Daş-Evcimen is a scholar working on Cell Biology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Net Daş-Evcimen has authored 15 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cell Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Net Daş-Evcimen's work include Aldose Reductase and Taurine (9 papers), Polyamine Metabolism and Applications (4 papers) and Biochemical effects in animals (3 papers). Net Daş-Evcimen is often cited by papers focused on Aldose Reductase and Taurine (9 papers), Polyamine Metabolism and Applications (4 papers) and Biochemical effects in animals (3 papers). Net Daş-Evcimen collaborates with scholars based in Türkiye, United States and Slovakia. Net Daş-Evcimen's co-authors include Gerard King, Oya Bozdağ‐Dündar, Rahmiye Ertan, Svorad Štolc, Fügen Aktan, Milan Štefek, Nuriye Nuray Ulusu, Çi̇men Karasu, Síbel Süzen and Eugen J. Verspohl and has published in prestigious journals such as European Journal of Medicinal Chemistry, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Pharmacological Research.

In The Last Decade

Net Daş-Evcimen

15 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Net Daş-Evcimen Türkiye 9 245 134 124 97 95 15 623
Chandrashekhar D. Kamat United States 11 256 1.0× 86 0.6× 105 0.8× 58 0.6× 67 0.7× 14 655
Mona F. El-Azab Egypt 18 306 1.2× 76 0.6× 62 0.5× 41 0.4× 62 0.7× 37 790
J. Peyroux France 12 170 0.7× 217 1.6× 118 1.0× 194 2.0× 50 0.5× 31 661
Riyaz Mohamed United States 21 480 2.0× 85 0.6× 57 0.5× 56 0.6× 150 1.6× 43 1.2k
Soledad Miranda Chile 12 459 1.9× 48 0.4× 283 2.3× 58 0.6× 36 0.4× 12 936
María L. Rodríguez Spain 10 374 1.5× 50 0.4× 72 0.6× 50 0.5× 54 0.6× 12 837
Márton Mohás Hungary 11 328 1.3× 174 1.3× 319 2.6× 69 0.7× 29 0.3× 21 890
KOICHI YASUMURA Japan 10 150 0.6× 181 1.4× 103 0.8× 301 3.1× 67 0.7× 22 590
Rosa Maisto Italy 16 302 1.2× 35 0.3× 88 0.7× 76 0.8× 17 0.2× 22 678
Hirotaka Tsubouchi Japan 8 232 0.9× 208 1.6× 269 2.2× 164 1.7× 12 0.1× 9 827

Countries citing papers authored by Net Daş-Evcimen

Since Specialization
Citations

This map shows the geographic impact of Net Daş-Evcimen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Net Daş-Evcimen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Net Daş-Evcimen more than expected).

Fields of papers citing papers by Net Daş-Evcimen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Net Daş-Evcimen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Net Daş-Evcimen. The network helps show where Net Daş-Evcimen may publish in the future.

Co-authorship network of co-authors of Net Daş-Evcimen

This figure shows the co-authorship network connecting the top 25 collaborators of Net Daş-Evcimen. A scholar is included among the top collaborators of Net Daş-Evcimen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Net Daş-Evcimen. Net Daş-Evcimen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Daş-Evcimen, Net, et al.. (2018). Synthesis and Aldose Reductase Inhibitory Effect of Some New Hydrazinecarbothioamides and 4-Thiazolidinones Bearing an Imidazo[2,1-b]Thiazole Moiety. Turkish Journal of Pharmaceutical Sciences. 16(1). 1–7. 7 indexed citations
2.
Hasçiçek, Canan, Ceyda Tuba Şengel-Türk, Síbel A. Özkan, et al.. (2017). Fulvestrant-loaded polymer-based nanoparticles for local drug delivery: Preparation and in vitro characterization. Journal of Drug Delivery Science and Technology. 40. 73–82. 16 indexed citations
3.
Hasçiçek, Canan, Ceyda Tuba Şengel-Türk, Mehmet Gümüştaş, et al.. (2015). Influence of Polymer Molecular Weight on in-vitro Characteristics and Cytotoxicity of Fulvestrant Loaded Nanoparticles. Current Drug Therapy. 9(4). 239–249. 5 indexed citations
4.
Daş-Evcimen, Net, et al.. (2013). Aldose Reductase Inhibitory Potential of Several Thiazolyl-thiazolidine- 2,4-Diones. Letters in Drug Design & Discovery. 10(5). 415–419. 4 indexed citations
5.
King, George L. & Net Daş-Evcimen. (2010). Role of protein kinase C in diabetic complications. Expert Review of Endocrinology & Metabolism. 5(1). 77–88. 8 indexed citations
6.
Daş-Evcimen, Net, et al.. (2010). Evaluation of rat kidney aldose reductase inhibitory activity of some N-acetyl dehydroalanine derivatives. Medicinal Chemistry Research. 20(4). 453–460. 1 indexed citations
7.
Daş-Evcimen, Net, Özlem Yıldırım, & Síbel Süzen. (2009). Relationship between Aldose reductase and superoxide dismutase inhibition capacities of indole-based analogs of melatonin derivatives. Archives of Biological Sciences. 61(4). 675–681. 7 indexed citations
8.
Bozdağ‐Dündar, Oya, et al.. (2008). Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones. Bioorganic & Medicinal Chemistry. 16(14). 6747–6751. 42 indexed citations
9.
Daş-Evcimen, Net, et al.. (2008). In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones. Journal of Enzyme Inhibition and Medicinal Chemistry. 23(3). 297–301. 10 indexed citations
10.
Bozdağ‐Dündar, Oya, et al.. (2008). Synthesis and aldose reductase inhibitory activity of some new chromonyl-2,4-thiazolidinediones. European Journal of Medicinal Chemistry. 43(11). 2412–2417. 34 indexed citations
11.
Şüküroğlu, Murat, et al.. (2007). Screening and evaluation of rat kidney aldose reductase inhibitory activity of some pyridazine derivatives. Medicinal Chemistry Research. 15(7-8). 443–451. 5 indexed citations
12.
Daş-Evcimen, Net & Gerard King. (2007). The role of protein kinase C activation and the vascular complications of diabetes. Pharmacological Research. 55(6). 498–510. 383 indexed citations
13.
Süzen, Síbel, et al.. (2007). Preliminary evaluation of rat kidney aldose reductase inhibitory activity of 2-phenylindole derivatives: affiliation to antioxidant activity. Medicinal Chemistry Research. 16(3). 112–118. 15 indexed citations
14.
Ulusu, Nuriye Nuray, Net Daş-Evcimen, Fügen Aktan, et al.. (2002). In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca2+-ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1588(1). 71–78. 64 indexed citations
15.
Ulusu, Nuriye Nuray, Net Daş-Evcimen, Fügen Aktan, et al.. (2002). In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca 2+ -ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E The ADIC (Antioxidants in Diabetes-Induced Complications) Study Group. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026